Jung‐Yoon Yoo

2.0k total citations
60 papers, 1.6k citations indexed

About

Jung‐Yoon Yoo is a scholar working on Molecular Biology, Reproductive Medicine and Immunology. According to data from OpenAlex, Jung‐Yoon Yoo has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Reproductive Medicine and 20 papers in Immunology. Recurrent topics in Jung‐Yoon Yoo's work include Endometriosis Research and Treatment (23 papers), Reproductive System and Pregnancy (18 papers) and Estrogen and related hormone effects (10 papers). Jung‐Yoon Yoo is often cited by papers focused on Endometriosis Research and Treatment (23 papers), Reproductive System and Pregnancy (18 papers) and Estrogen and related hormone effects (10 papers). Jung‐Yoon Yoo collaborates with scholars based in South Korea, United States and Japan. Jung‐Yoon Yoo's co-authors include Ho‐Geun Yoon, Tae Hoon Kim, Jae‐Wook Jeong, Asgerally T. Fazleabas, Bruce A. Lessey, Steven L. Young, Kyung‐Chul Choi, Yoo‐Hyun Lee, Bon Jeong Ku and Jung‐Ho Shin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Jung‐Yoon Yoo

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung‐Yoon Yoo South Korea 22 662 647 638 469 175 60 1.6k
Julia T. Arnold United States 25 505 0.8× 338 0.5× 571 0.9× 352 0.8× 230 1.3× 48 1.9k
Andrzej Semczuk Poland 24 394 0.6× 245 0.4× 743 1.2× 493 1.1× 280 1.6× 128 1.8k
Feng Xie China 23 156 0.2× 403 0.6× 682 1.1× 267 0.6× 469 2.7× 86 1.6k
Satyan Kalkunte United States 20 128 0.2× 623 1.0× 413 0.6× 569 1.2× 152 0.9× 27 1.4k
Michihiro Tanikawa Japan 19 204 0.3× 135 0.2× 534 0.8× 154 0.3× 186 1.1× 68 1.1k
Zhongping Cheng China 19 173 0.3× 240 0.4× 600 0.9× 125 0.3× 308 1.8× 72 1.2k
Ashwini L. Chand Australia 22 219 0.3× 329 0.5× 753 1.2× 69 0.1× 242 1.4× 41 1.6k
Ece Konaç Türkiye 19 176 0.3× 88 0.1× 468 0.7× 45 0.1× 280 1.6× 59 941
Yu Song China 20 62 0.1× 136 0.2× 535 0.8× 110 0.2× 328 1.9× 58 1.2k

Countries citing papers authored by Jung‐Yoon Yoo

Since Specialization
Citations

This map shows the geographic impact of Jung‐Yoon Yoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Yoon Yoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Yoon Yoo more than expected).

Fields of papers citing papers by Jung‐Yoon Yoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Yoon Yoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Yoon Yoo. The network helps show where Jung‐Yoon Yoo may publish in the future.

Co-authorship network of co-authors of Jung‐Yoon Yoo

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Yoon Yoo. A scholar is included among the top collaborators of Jung‐Yoon Yoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Yoon Yoo. Jung‐Yoon Yoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, S.-O., et al.. (2025). Applications of Recombinase Polymerase Amplification in Forensic Science. Journal of Experimental & Biomedical Sciences/Biomedical Science Letters. 31(2). 99–114.
2.
Yoo, Jung‐Yoon, et al.. (2025). Recent Trends in the Use of Rodent Models in Kidney Fibrosis Research. Journal of Experimental & Biomedical Sciences/Biomedical Science Letters. 31(2). 89–98.
4.
Rahman, Md Saidur, Seock‐Jin Chung, Jung‐Yoon Yoo, et al.. (2025). Nanoceria as a non-steroidal anti-inflammatory drug for endometriosis theranostics. Journal of Controlled Release. 378. 1015–1029. 5 indexed citations
5.
Yoon, Ho‐Geun, et al.. (2025). Plumbagin ameliorates renal fibrosis by suppressing epithelial-mesenchymal transition. Biochemical and Biophysical Research Communications. 750. 151325–151325. 2 indexed citations
6.
Kim, Hyun Seung, et al.. (2024). Deubiquitinase inhibitor bAP-15 suppresses renal epithelial to mesenchymal transition via inhibition of p300 stability. Biochemical and Biophysical Research Communications. 741. 151095–151095. 2 indexed citations
7.
Tran, Dinh Nam, Lyndon M. Coghill, Mark Hunter, et al.. (2024). ARG1 Is a Potential Prognostic Marker in Metastatic Endometrial Cancer. Reproductive Sciences. 31(6). 1632–1641. 4 indexed citations
8.
hyunsik, kim, et al.. (2024). JMJD4 promotes tumor progression via inhibition of the PDCD5-TP53 pathway. BMB Reports. 58(2). 64–69.
9.
Jo, Minjeong, Soonjae Hwang, Chang-Gun Lee, et al.. (2023). Promotion of Colitis in B Cell-Deficient C57BL/6 Mice Infected with Enterotoxigenic Bacteroides fragilis. International Journal of Molecular Sciences. 25(1). 364–364. 7 indexed citations
10.
Yoo, Jung‐Yoon, Tae Hoon Kim, Jung‐Ho Shin, et al.. (2022). Loss of MIG-6 results in endometrial progesterone resistance via ERBB2. Nature Communications. 13(1). 1101–1101. 29 indexed citations
11.
Jeong, Mi‐Hyeon, Soo‐Yeon Park, Seung‐Hyun Lee, et al.. (2019). EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric Cancer. Clinical Cancer Research. 25(12). 3617–3629. 23 indexed citations
12.
Kim, Tae Hoon, Jung‐Yoon Yoo, Kyung‐Chul Choi, et al.. (2019). Loss of HDAC3 results in nonreceptive endometrium and female infertility. Science Translational Medicine. 11(474). 106 indexed citations
13.
Yoo, Jung‐Yoon, Tae Hoon Kim, Asgerally T. Fazleabas, et al.. (2017). KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance. Scientific Reports. 7(1). 6765–6765. 107 indexed citations
14.
Kim, Tae Hoon, Jung‐Yoon Yoo, Zhong Wang, et al.. (2015). ARID1A Is Essential for Endometrial Function during Early Pregnancy. PLoS Genetics. 11(9). e1005537–e1005537. 67 indexed citations
15.
Yoo, Jung‐Yoon, Tae Hoon Kim, Jae Hee Lee, et al.. (2015). Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling. Biochemical and Biophysical Research Communications. 462(4). 409–414. 13 indexed citations
16.
Kim, Tae Hoon, Jung‐Yoon Yoo, Hong Im Kim, et al.. (2014). Mig-6 Suppresses Endometrial Cancer Associated with Pten Deficiency and ERK Activation. Cancer Research. 74(24). 7371–7382. 36 indexed citations
18.
Yoo, Jung‐Yoon, Kyung‐Chul Choi, Hee‐Bum Kang, et al.. (2010). Histone deacetylase 3 is selectively involved in L3MBTL2‐mediated transcriptional repression. FEBS Letters. 584(11). 2225–2230. 13 indexed citations
19.
Jeon, Bu‐Nam, Jung‐Yoon Yoo, Won‐Il Choi, et al.. (2008). Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses Transcription of the Tumor Suppressor Rb Gene via Binding Competition with Sp1 and Recruitment of Co-repressors. Journal of Biological Chemistry. 283(48). 33199–33210. 83 indexed citations
20.
Yoo, Jung‐Yoon, et al.. (2006). GIT Physio-chemical Modelling - Critical Review. 367. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026